Evidence map›Paper›PMID 23478306›Full record

ReviewJournal of Alzheimer's disease : JAD2013

Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Lidia Glodzik, Catherine Randall, Henry Rusinek, Mony J de Leon

Abstract readReview
In one paragraph

Review in Journal of Alzheimer's disease : JAD, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed, 3 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 3 syntheses or guidelines pooled it, 137 citations in OpenAlex.

  1. Effects of candesartan on cerebral microvascular function in mild cognitive impairment: Results of two clinical trials.International journal of stroke : official journal of the International Stroke Society · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Evidence of cortical vascular impairments in early stage of Alzheimer's transgenic mice: Optical imaging.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. The dependence of COImaging neuroscience (Cambridge, Mass.) · 2025
    Article
  18. Article
  19. Parkinson's disease cerebrovascular reactivity pattern: A feasibility study.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  20. CD8American journal of physiology. Regulatory, integrative and comparative physiology · 2024
    Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lidia GlodzikCenter for Brain Health, Department of Psychiatry, New York University School of Medicine, New York, NY 10016, USA. Lidia.Glodzik@nyumc.org
Catherine Randall
Henry Rusinek
Mony J de Leon
New York University · US

Funding

PSYCHOSOCIAL COREP30AG008051 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHAO, YONGZHAO · 1990 to 2019
$36.1M
PREDICTORS OF COGNITIVE DECLINE IN NORMAL AGINGR01AG012101 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DE LEON, MONY J., RUSINEK, HENRY · 1993 to 2015
$6.7M
Blood Pressure, Cerebral Perfusion & Cognitive Outcome In Hypertension.R01HL111724 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI GLODZIK, LIDIA · 2012 to 2025
$6.6M
CLINICAL CORRELATES OF LONGITUDINAL PET CHANGES IN ADR01AG013616 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DE LEON, MONY J. · 1995 to 2013
$6.2M
Biomarkers in Early Alzheimer's Disease (AD).R01AG022374 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DE LEON, MONY J., RUSINEK, HENRY · 2004 to 2015
$5.2M
NHLBI NIH HHS HL111724-01NHLBI NIH HHS R01 HL111724NIA NIH HHS AG022374NIA NIH HHS AG13616NIA NIH HHS NIH-NIA AG12101NIA NIH HHS P30 AG008051NIA NIH HHS R01 AG012101NIA NIH HHS R01 AG013616NIA NIH HHS R01 AG022374
6 · The paper itself

Abstract

There is growing evidence that cerebrovascular reactivity to carbon dioxide (CVRCO2) is impaired in Alzheimer's disease (AD). Preclinical and animal studies suggest chronic hypercontractility in brain vessels in AD. We review (a) preclinical studies of mechanisms for impaired CVRCO2 in AD; (b) clinical studies of cerebrovascular function in subjects with AD dementia, mild cognitive impairment (MCI), and normal cognition. Although results of clinical studies are inconclusive, an increasing number of reports reveal an impairment of vascular reactivity to carbon dioxide in subjects with AD, and possibly also in MCI. Thus, CVRCO2 may be an attractive means to detect an early vascular dysfunction in subjects at risk.

Indexed as

AgedAlzheimer DiseaseAnimalsBrainCarbon DioxideCardiovascular DiseasesCognitive DysfunctionDementia, VascularDisease Models, AnimalEndothelium, VascularHumansHypercapniaImage EnhancementImage Interpretation, Computer-AssistedMagnetic Resonance AngiographyNeuropsychological TestsCarbon Dioxide

Identifiers

PMID23478306
PMCPMC3776495
OpenAlexW1490034507

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.